The $199 million settlement, announced Feb. 12, ends a lawsuit that J&J had filed in June 2020 in U.S. District Court in Delaware. J&J Surgical Vision had claimed that Alcon femtosecond laser-assisted cataract surgery devices, including the company’s LenSx device, infringed on one or more claims in 12 of J&J’s U.S. patents.
On top of the one-time payment, the two companies have exchanged cross-licenses of certain intellectual property and other mutually agreed covenants and releases. The payment secures the patent rights for Alcon. It also resolves various worldwide intellectual property disputes relating to this matter.
Alcon acquired LenSx Lasers in 2010.